226 related articles for article (PubMed ID: 29645076)
61. Radiotherapy for Hepatocellular Carcinoma.
Yu Y; Feng M
Semin Radiat Oncol; 2018 Oct; 28(4):277-287. PubMed ID: 30309638
[TBL] [Abstract][Full Text] [Related]
62. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
[TBL] [Abstract][Full Text] [Related]
63. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
Soni PD; Palta M
Dig Dis Sci; 2019 Apr; 64(4):1008-1015. PubMed ID: 30868409
[TBL] [Abstract][Full Text] [Related]
64. [Stereotactic body radiation therapy in the management of liver tumours].
Jacob J; Nguyen F; Deutsch E; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
[TBL] [Abstract][Full Text] [Related]
65. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
Moon DH; Wang AZ; Tepper JE
Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
[TBL] [Abstract][Full Text] [Related]
66. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
McPartlin AJ; Dawson LA
Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
[TBL] [Abstract][Full Text] [Related]
67. Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma.
Bujold A; Dawson LA
Cancer Radiother; 2011 Feb; 15(1):54-63. PubMed ID: 21239204
[TBL] [Abstract][Full Text] [Related]
68. Role of interventional radiology in the management of hepatocellular carcinoma: current status.
Holzwanger DJ; Madoff DC
Chin Clin Oncol; 2018 Oct; 7(5):49. PubMed ID: 30180753
[TBL] [Abstract][Full Text] [Related]
69. Single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus.
Shirai S; Sato M; Suwa K; Kishi K; Shimono C; Kawai N; Tanihata H; Minamiguchi H; Nakai M
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):824-31. PubMed ID: 18755560
[TBL] [Abstract][Full Text] [Related]
70. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma.
Xu LT; Zhou ZH; Lin JH; Chen Z; Wang K; Wang P; Zhu XY; Shen YH; Meng ZQ; Liu LM
Eur J Surg Oncol; 2011 Mar; 37(3):245-51. PubMed ID: 21195578
[TBL] [Abstract][Full Text] [Related]
71. The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study.
Wada Y; Takami Y; Matsushima H; Tateishi M; Ryu T; Yoshitomi M; Matsumura T; Saitsu H
Intern Med; 2018 May; 57(10):1345-1353. PubMed ID: 29279513
[TBL] [Abstract][Full Text] [Related]
72. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
73. Hepatic tumours and radiotherapy.
Rio E; Mornex F; Maingon P; Peiffert D; Parent L
Cancer Radiother; 2022; 26(1-2):266-271. PubMed ID: 34953707
[TBL] [Abstract][Full Text] [Related]
74. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies.
Fuss M; Salter BJ; Cavanaugh SX; Fuss C; Sadeghi A; Fuller CD; Ameduri A; Hevezi JM; Herman TS; Thomas CR
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1245-56. PubMed ID: 15234062
[TBL] [Abstract][Full Text] [Related]
75. Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma.
Kim JW; Kim DY; Han KH; Seong J
Dig Liver Dis; 2019 Mar; 51(3):445-451. PubMed ID: 30503296
[TBL] [Abstract][Full Text] [Related]
76. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
77. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
78. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
[TBL] [Abstract][Full Text] [Related]
79. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
Titano J; Voutsinas N; Kim E
Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
[TBL] [Abstract][Full Text] [Related]
80. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
